Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won

Anaplastic lymphoma kinase (ALK) translocations are responsible of neoplastic transformation in a limited subset of non-small cell lung cancer (NSCLC) patients. In recent years outcomes of these patients improved due to the development and clinical availability of specific and extremely active targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabbò, Fabrizio, Reale, Maria Lucia, Bironzo, Paolo, Scagliotti, Giorgio V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Looking for Chimeras in NSCLC: Widen Therapeutic Options Targeting Oncogenic Fusions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815358/
https://www.ncbi.nlm.nih.gov/pubmed/33489817
http://dx.doi.org/10.21037/tlcr-20-372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815358/
https://www.ncbi.nlm.nih.gov/pubmed/33489817
http://dx.doi.org/10.21037/tlcr-20-372

Ejemplares similares